SCHEMBL20510965

SCHEMBL20510965

COC(=O)c1ccc(CNc2c(C)noc2C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.51
▸ CA2 P00918 3/20 0.51
▸ AR P10275 1/20 0.47
▸ BRD4 O60885 2/20 0.46
▸ LOXL2 Q9Y4K0 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TAS2R8 Q9NYW2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ BRD2 P25440 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GABRA5 P31644 1/20 0.42
▸ ATAD2 Q6PL18 1/20 0.42
▸ CYP4A11 Q02928 1/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20511088 0.86 GAA (0.49) ALDH1A1MEN1KMT2ALMNAHPGD
SCHEMBL16845182 0.79 BRD4 (0.56) BRD4ALDH1A1MEN1KMT2ALMNA
SCHEMBL22609276 0.76 ALDH1A1 (0.53) ALDH1A1KMT2APOLBSMN1; SMN2GABRA5
SCHEMBL20511030 0.75 MAPT (0.55) ALDH1A1MEN1KMT2ALMNAHPGD
SCHEMBL20510983 0.74 ALDH1A1 (0.45) ARBRD4LOXL2ALDH1A1MEN1
SCHEMBL13934091 0.73 CA1 (0.87) CA1CA2LOXL2ALDH1A1MEN1
SCHEMBL17618029 0.71 CA1 (0.77) CA1CA2LOXL2ALDH1A1MEN1
SCHEMBL1064735 0.71 CA1 (0.60) CA1CA2LOXL2ALDH1A1MEN1
SCHEMBL9016956 0.70 LMNA (0.68) CA1CA2LOXL2ALDH1A1MEN1
SCHEMBL20510987 0.70 ALDH1A1 (0.79) ALDH1A1MEN1KMT2ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12486258-B2 Compounds and methods for regulating insulin secretion THE BROAD INSTITUTE, INC. (US) 2025-12-02 — — US disclosed
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION THE BROAD INSTITUTE, INC. (US) 2023-05-11 — — US disclosed
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION THE BROAD INSTITUTE, INC. (US) 2023-05-11 — — US disclosed
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION THE BROAD INSTITUTE, INC. (US) 2023-05-11 — — US disclosed
US-11555031-B2 Compounds and methods for regulating insulin secretion THE BROAD INSTITUTE, INC. (US) 2023-01-17 — — US disclosed
EP-3601326-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION The Broad Institute, Inc. (US) 2020-02-05 — — EP disclosed
WO-2018175324-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION THE BROAD INSTITUTE, INC. (US) 2018-09-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142508-A1 COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION IAPP, GPR119, PNLIP CA1 2634/4885CA2 2276/4885AR 3845/4885
US-11555031-B2 Compounds and methods for regulating insulin secretion IAPP, GPR119, INSR CA1 2703/4885CA2 2366/4885AR 2661/4885
US-12486258-B2 Compounds and methods for regulating insulin secretion IAPP, GPR119, PNLIP CA1 2634/4885CA2 2276/4885AR 3845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback